Clinical Trials Browser

Hepatocellular Carcinoma Resectable × Doxorubicin × Gastrointestinal × Clear all

NCT05766605 2023-03-13

Applicability of PDOX in Patients With Primary Liver Cancer: A Randomized Controlled Trial

Phase 3 Unknown

Gastrointestinal

Hepatocellular Carcinoma Resectable